S. 4430 would establish an interagency task force to facilitate sharing of information between the Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA). The bill also would require PTO to report to the Congress on how often the FDA provides information through the task force and whether that information is used in patent examinations. CBO estimates that enacting S. 4430 would not affect direct spending or revenues. CBO has not estimated the discretionary costs of implementing the bill. The bill would impose an intergovernmental and private- sector mandate as defined in the Unfunded Mandates Reform Act that would not exceed the annual respective thresholds of $92 million and $184 million (adjusted annually for inflation).